Table TDI-8. Primary use of stimulants of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (i) New clients by country and type of stimulant (%)

Country		Amphetamines	%	Ecstasy	%	Other stimulants	%	Total stimulants
Belgium		375	87.2	46	10.7	9	2.1	430
Bulgaria		13	100.0	0	0.0	0	0.0	13
Czech Republic		2628	99.5	5	0.2	9	0.3	2642
Denmark		206	95.4	10	4.6	0	0.0	216
Germany	(1)	0	0.0	0	0.0	0	0.0	1607
Estonia		10	100.0	0	0.0	0	0.0	10
Ireland		22	30.1	50	68.5	1	1.4	73
Greece		1	100.0	0	0.0	0	0.0	1
Spain	(2)	237	64.2	110	29.8	22	6.0	369
France		17	47.2	16	44.4	3	8.3	36
Italy		31	24.4	76	59.8	20	15.7	127
Cyprus		1	50.0	0	0.0	1	50.0	2
Latvia		137	93.2	1	0.7	9	6.1	147
Lithuania	(1)	:	:	:	:	:	:	15
Luxembourg		:	:	:	:	:	:	0
Hungary		277	89.6	28	9.1	4	1.3	309
Malta		0	0.0	4	100.0	0	0.0	4
Netherlands		378	88.3	33	7.7	17	4.0	428
Austria		41	80.4	5	9.8	5	9.8	51
Poland	(2)	218	93.2	11	4.7	5	2.1	234
Portugal		2	28.6	4	57.1	1	14.3	7
Romania		3	60.0	2	40.0	0	0.0	5
Slovenia		3	75.0	1	25.0	0	0.0	4
Slovakia		283	99.3	2	0.7	0	0.0	285
Finland		57	98.3	0	0.0	1	1.7	58
Sweden		306	95.9	9	2.8	4	1.3	319
United Kingdom		1640	81.9	268	13.4	94	4.7	2002
Croatia		49	81.7	6	10.0	5	8.3	60
Turkey		0	0.0	22	95.7	1	4.3	23
Norway		:	:	:	:	:	:	:
Total		6935	73.2	709	7.5	211	2.2	9477

Notes:

 : Indicates no data available 

 All types of treatment centres as defined by TDI Protocol 2.0 are included. 

 Percentages are of clients in treatment for stimulants as primary drug 

 (1) For Germany and Lithuania only the aggregated data for Stimulants Total are available. 

 (2) Last data available refer to 2008.  

 See also ‘General notes for interpreting data’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2010 — Standard table 3. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)